英国 美国 香港 日本 瑞士
贵金属投资品牌
你当前所在页面: 大田环球首页 > 新闻资讯 > 财经新闻 > 辉瑞和武田药品将获21.5亿美元专利侵权赔偿金

辉瑞和武田药品将获21.5亿美元专利侵权赔偿金

两家仿制药生产商同意向辉瑞制药有限公司和武田药品工业支付21.5亿美元的专利侵权损害赔偿,因它们在胃灼热治疗药Protonix的美国专利到期前就开始销售该药的仿制药。


本文来源: 大田环球贵金属

猜你喜欢:炒黄金MT4布林带的应用教程

贵金属投资网

Risk Warning

Trading bullion and financial instruments carries significant risks and may not be suitable for all investors, requiring careful consideration of investment objectives, experience, and risk tolerance. Key risks include market volatility, leverage risks that can amplify gains or losses, liquidity issues that may prevent executing trades at desired prices, and technical failures in online trading systems. Prices fluctuate unpredictably, and past performance does not guarantee future results. CIDT Global Bullion Limited provides general market commentary but does not offer investment advice and is not liable for any losses incurred from reliance on its information, which may change without notice.


Jurisdiction Disclaimer

CIDT Global Bullion Limited's services are subject to local regulations and may not be available in all jurisdictions. Users are responsible for ensuring compliance with their local laws. Services are not provided in regions where they are prohibited by law, under international sanctions, or require licensing that the company does not hold. By using the platform, users confirm they are not in a restricted jurisdiction and accept full responsibility for legal compliance. The company reserves the right to decline or terminate services in restricted areas without prior notice.

QQ客服 在线客服 微信客服